上海复星医药(集团)股份有限公司2024年年度A股权益分派实施公告
Shang Hai Zheng Quan Bao·2025-07-24 20:00

Core Viewpoint - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced a cash dividend distribution of RMB 0.32 per share (pre-tax) for the fiscal year 2024, approved at the shareholders' meeting on June 24, 2025 [2][4]. Summary by Sections Dividend Distribution Details - The cash dividend of RMB 0.32 per share (pre-tax) will be distributed to all eligible A-share shareholders registered by the close of trading on August 1, 2025 [3][4]. - The total cash dividend distribution is expected to amount to approximately RMB 844.66 million (pre-tax), with A-share shareholders receiving about RMB 671.55 million (pre-tax) [4]. Shareholder Eligibility - Eligible shareholders include all A-share shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the record date [3]. - Shares repurchased and held in a special account will not participate in the distribution [3]. Taxation Information - Individual shareholders holding A-shares will be subject to different tax rates based on their holding period, with a maximum tax rate of 20% for shares held for one month or less [8]. - For qualified foreign institutional investors (QFIIs), a 10% withholding tax will apply, resulting in a net cash dividend of RMB 0.288 per share [10]. - Other investors will receive the full cash dividend of RMB 0.32 per share, with tax obligations to be fulfilled by the shareholders themselves [11]. Implementation Method - The cash dividends will be distributed through the clearing system of China Securities Depository and Clearing Corporation Limited, with designated trading investors able to receive their dividends on the payment date [6][11]. - Shanghai Fosun High Technology (Group) Co., Ltd. will receive its cash dividends directly from the company [7].